8/5/2026 – ACADIA Pharmaceuticals had its price target raised by Oppenheimer Holdings, Inc. from $23.00 to $25.00. 8/5/2026 – ACADIA Pharmaceuticals had its “market outperform” rating reaffirmed by Citigroup Inc..8/5/2026 – ACADIA Pharmaceuticals had its price target raised by Citizens Jmp from $35.00 to $36.00. 7/21/2026 – ACADIA Pharmaceuticals had its price target raised by BMO Capital Markets from $34.00 to $36.00. Get ACADIA Pharmaceuticals Inc alerts:ACADIA Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of innovative therapies for central nervous system (CNS) disorders. Featured StoriesReceive News & Ratings for ACADIA Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ACADIA Pharmaceuticals Inc and related companies with MarketBeat.com's FREE daily email newsletter.